Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 119114
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.119114
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.119114
Table 3 Integrative landscape of molecular subtypes and immune phenotypes
| Molecular subtype | Spatial phenotype | Key genomic drivers | Dominant immune mechanism | Recommended strategy |
| Epstein-Barr virus+ | Inflamed (hot) | 9p24.1 amp, PIK3CA mut | Viral pathogen-associated molecular patterns; constitutive programmed death-ligand 1 | Programmed cell death protein 1 monotherapy |
| Microsatellite instability | Inflamed (hot) | Deficient mismatch repair, high tumor mutational burden | Neoantigen-driven recruitment | Dual checkpoint blockade |
| Genomically stable | Excluded (cold) | CDH1/RHOA mut, CLDN18.2 | TGF-β fibrosis; myofibroblastic cancer-associated fibroblasts barriers | Anti-CLDN18.2/TGF-β inhibitors |
| Chromosomal instability | Desert/variable | TP53 mut, receptor tyrosine kinase amp, somatic copy number alterations | Human leukocyte antigen loss of heterozygosity; myeloid-driven suppression | Targeted + immune checkpoint inhibitors (e.g., human epidermal growth factor receptor 2-directed) |
- Citation: Yao ZY, Ma LJ, Han ZX, Ji GJ. Evolving landscape of the gastric cancer immune microenvironment: From spatial architecture to precision biomarkers. World J Gastrointest Oncol 2026; 18(6): 119114
- URL: https://www.wjgnet.com/1948-5204/full/v18/i6/119114.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.119114